FLAT Prices Act

Fact Sheet API

Bill Number

S 366

Introduced

Feb 6, 2019

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)

Sponsor

Cosponsors

Topics

Business records Drug safety, medical device, and laboratory regulation Government information and archives Health Health care costs and insurance Inflation and prices Licensing and registrations Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act

This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.

Actions

Feb 6, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Feb 6, 2019

Introduced in Senate

Amendments

Related Bills